top of page

All Technologies & Services

Human-Relevant Technologies and Translational Study Design for Advanced In-Vitro Research NAMina Bio offers a growing portfolio of products and services designed to support human-relevant translational research, advanced 3D models, dynamic in-vitro systems, and decision-ready experimental workflows. Our current portfolio includes 3D tumor model development, patient-derived tumoroid profiling, drug response and resistance testing, tumor–immune co-culture modeling, 3D bioprinting study design, and partner-enabled dynamic/fluidic platforms.
Human-Relevant Technologies and Translational Study Design for Advanced In-Vitro Research NAMina Bio offers a growing portfolio of products and services designed to support human-relevant translational research, advanced 3D models, dynamic in-vitro systems, and decision-ready experimental workflows. Our current portfolio includes 3D tumor model development, patient-derived tumoroid profiling, drug response and resistance testing, tumor–immune co-culture modeling, 3D bioprinting study design, and partner-enabled dynamic/fluidic platforms.…

    A Growing Translational Portfolio

    NAMina Bio is building more than a catalog. We are developing an integrated translational architecture where advanced in-vitro technologies, biological models, dynamic culture systems, analytics, and scientific interpretation can be combined into fit-for-purpose workflows.

    Our goal is to help academic, biotech, pharma, and technology partners design more predictive, human-relevant studies while reducing reliance on traditional animal models.

    Looking for a customized translational workflow?

    Many NAMina Bio offerings can be adapted to specific biological questions, disease areas, model systems, and technology requirements. If you are interested in a customized study, feasibility review, partner-enabled product, or integrated NAM-based workflow, please contact us to discuss the best path forward.

    bottom of page